Rénibus Therapeutics Funding & Investors
Southlake, TX
Rénibus Therapeutics is a biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention, treatment, and diagnostic testing of kidney disease.
renibus.comTotal Amount Raised: $214,724,496
Rénibus Therapeutics Funding Rounds
Series B
$25,000,000
Series B
$47,000,000
Series Unknown
$63,805,500
Convertible Note
$23,000,000
Debt Financing
$10,000,000
Debt Financing Investors
Oxford FinanceSeries A
$20,000,000
Series A
$15,000,000
Series Unknown
$10,919,000
Funding info provided by Diffbot.